With over three decades of experience in public health management, Adelaide Maria Caldas Cabral has been a key figure in shaping healthcare policy, services, and institutional transformation in Brazil. She holds a degree in Speech Therapy from the Catholic University of Pernambuco, a Master’s in Adolescent Medicine (Hebiatrics) from the University of Pernambuco (UPE), and a specialization in Operational Excellence in Healthcare from the Albert Einstein Hospital. Her multidisciplinary background combines clinical insight, strategic management, and a strong commitment to innovation and quality in healthcare delivery. Adelaide has held several high-impact positions across municipal, state, and federal levels, including Executive Secretary of Health Regulation for the State of Pernambuco, General Director of the Metropolitan Hospitals Miguel Arraes and Pelópidas Silveira, and Health Secretary for the cities of Gravatá, Cabo de Santo Agostinho, and Ipojuca. She also served as Director of Programs at the Executive Secretariat of the Ministry of Health and as Human Resources Manager at Hemobrás, where she currently plays a strategic role in aligning management, innovation, and human development. At Hemobrás – the Brazilian Company of Blood Products and Biotechnology – Adelaide is part of a pioneering institution under the Ministry of Health, whose mission is to ensure national self-sufficiency in the production of plasma-derived medicines and strategic biopharmaceuticals. Hemobrás is a public company that plays a vital role in the treatment of chronic and rare diseases, ensuring access to essential therapies through advanced technological platforms and strict regulatory standards. The company is a model of public innovation, combining applied research, industrial-scale production, and long-term partnerships in biotechnology. Currently, Hemobrás is at a pivotal moment of expansion and strengthening of global partnerships to accelerate the development of new biotechnological and plasma-derived products. This includes increased investment in research, technology transfer, and the pursuit of innovative therapies. The company is actively seeking collaborations that combine scientific excellence with social impact, aiming to co-develop solutions that serve both the Brazilian population and global health needs. Adelaide is particularly interested in connecting with companies, institutions, and thought leaders who are passionate about health innovation, collaborative R&D, and socially-driven biotech solutions. Her unique trajectory—bridging clinical expertise, high-level public administration, and industrial health innovation—positions her as a strong partner for initiatives that demand both strategic governance and technical depth. If you're looking to co-create transformative healthcare products, scale up biotechnological innovations, or expand into new markets with social relevance, Adelaide and Hemobrás are the right partners for meaningful collaboration. Let’s talk about how innovation can go further when it’s aligned with public purpose and global health equity.